Signal #114631 · SEC 8-K

$BEAM SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $BEAM filing catalyst

Why did $BEAM trigger an AI stock catalyst alert?

$BEAM triggered a Stock Catalyst AI alert on 2026-11-03 00:00:00 UTC for a SEC 8-K filing (AI Score: -1.0/10). Headline: Beam Therapeutics Reports Q3 Net Loss of $134.4M, Cash at $1.0B. Key points: - Q3 net loss widened to $134.4 million ($1.28 per share) vs. $112.6 million in Q3 prior year. - Cash, equivalents and marketable securities stood at $1.0 billion as of September 30, 2026. - U.S. BLA submission for Risto-cel in Sickle Cell Disease planned for late 2026.

How did $BEAM stock react after the SEC filing?

After the SEC 8-K for $BEAM, observed market reaction: T0 price $25.87. Past moves do not guarantee future results.

Where can I get real-time $BEAM SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $BEAM via Telegram and the VIP Web Terminal from €10/month.

$BEAM

$BEAM – Beam Therapeutics Reports Q3 Net Loss of $134.4M, Cash at $1.0B

Beam Therapeutics Inc.

2026-11-03 00:00:00 UTC · SEC 8-K · All $BEAM

Unlocked archive · Analyzed in <2s at T0

Neutral AI Sentiment (-1.0 / 10)

Q3 net loss widened to $134.4 million ($1.28 per share) vs. $112.6 million in Q3 prior year.
Cash, equivalents and marketable securities stood at $1.0 billion as of September 30, 2026.
U.S. BLA submission for Risto-cel in Sickle Cell Disease planned for late 2026.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →